Background and the purpose of the study: The objective of the present work was to improve bioavailability of cepodoxime proxetil through gastroretentive microballoon formulation. Methods: Microballoons of cefpodoxime proxetil were formulated by solvent evaporation and diffusion method employing hydroxypropylmethyl cellulose (HPMC) and ethyl cellulose (EC) polymers and characterized for particle size, surface morphology, incorporation efficiency, floating behavior, in vitro drug release study and differential scanning calorimetry (DSC). Results: The average particle size of formulated microballoons was in the range of 54.23±2.78-95.66±2.19µm. Incorporation efficiencies of over 83.77±0.85 % were achieved for the optimized formulations. Most of formulations remained buoyant (having buoyancy percentage maximum of 81.36±1.96%) for more than 12 hrs indicating good floating behavior of microballoons. Higher values of correlation coefficients were obtained with Higuchi's square root of time kinetic treatment heralding diffusion as predominant mechanism of drug release. Conclusion: Inferences drawn from in vitro studies suggest that microballoons may be potential delivery system for cefpodoxime proxetil with improvement in bioavailability in comparison to conventional dosage forms.
INTRODUCTION
Oral administration is the most convenient and preferred mean of drug delivery to the systemic circulation. Many attempts have been made to develop sustained-release preparations with extended clinical effects and reduced dosing frequency. In order to develop an oral drug delivery systems, it is necessary to optimize both the release rate of the drug and the residence time of the system within the gastrointestinal tract. Various approaches have been used to retain the dosage forms in the stomach (1) (2) (3) , as a way of increasing the gastric residence time (GRT) including floating (4-7), high density (3), mucoadhesive (8) , magnetic (9) , unfoldable, extendible, or swellable (10) , and superporous hydrogel systems (11) . Both natural and synthetic polymers have been used to prepare floating microspheres. Preparation of hollow microspheres or microballoons of ibuprofen by the emulsion-solvent diffusion method using acrylic polymers has been reported (12) . These systems allow prolonged residence time of dosage forms in the stomach and achievement of constant plasma levels; however, it is necessary to analyze the gastrointestinal transit behavior in human to confirm the suitability of the concept as far as the final design is concerned (13) . Cefpodoxime proxetil (CP) is a prodrug of the third generation cephalosporins, which is broad-spectrum antibiotic and is administered orally. In human, the absolute bioavailability of cefpodoxime proxetil administered as a 130mg tablet (equivalent to 100mg of cefpodoxime) is about 50% (14) . Reported studies have pointed possible reasons for low bioavailability as: low solubility, typical gelation behavior of CP particularly in acidic environments (15-17), and preabsorption of luminal metabolism into cefpodoxime acid by the action of digestive enzymes (18, 19) . It has been reported that the absorption of cefpodoxime proxetil is optimum at low pH (20) . The objective of the present work was to improve the bioavailability of cefpodoxime proxetil by formulating gastroretentive microballoons (hollow microspheres) in order to sustain the drug release and provide protection from intestinal milieu. In this study the influence of various process variables on particle size, drug loading, incorporation efficiency 
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Cefpodoxime proxetil was obtained as a gift sample from Lupin laboratories Limited, (Pune, India). Hydroxypropyl methyl cellulose, Ethyl cellulose and Tween 80 were purchased from Loba Chem Private Limited, (Mumbai, India). Ethanol was VXSSOLHG E\ 6' ¿QH &KHP /LPLWHG 0XPEDL India). Dichloromethane was purchased from CDH Limited, New Delhi, India. All chemicals/reagents used were of analytical grade. ,Q 9LWUR 'UXJ 5HOHDVH A USP paddle apparatus (Lab India, Mumbai, India) using 900 ml of 0.1 N HCl (pH 1.2) maintained at 37±0.5 °C with agitation speed of 75 rpm was used to study in vitro drug release (22) . Samples were withdrawn at interval of 2 hrs and analyzed spectrophotometrically at 263 nm. 
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Thermal analysis was carried out using a DSC unit (Pyris 6 DSC, Perkin-Elmer, Netherlands). Indium was used to calibrate the temperature scale and enthalpic response. Samples were placed in aluminum pans and heated at a scanning rate of 5°C/min from 30 to 400°C. Four samples i.e. pure cefpodoxime proxetil, pure HPMC, pure EC and cefpodoxime proxetil-loaded microballoons of HPMC and EC were analyzed. was a function of diffusion of solvents in the organic phase into aqueous phase. It has been reported that when the rate of the diffusion rate of solvent out of emulsion droplet is too slow, microspheres coalesced together. Conversely, when the diffusion of solvent is too fast, the solvent may diffuse into the aqueous phase before stable emulsion droplets are developed, causing aggregation of embryonic microsphere droplets (26) . Results of this study showed that the formation of microballoons is a function of process variables such as polymer concentration, solvent composition, rate of agitation and temperature. From the results of this study it was found that average particle size and wall thickness of microballoons increased by increase in the polymer concentration as it is apparent from observations of formulations P1 to P4 having average particle size in the range of 54.23±2.78-95.66±2.19 μm (Table  1 ). This may be attributed to increased viscosity of medium at higher polymer concentration resulting LQ HQKDQFHG LQWHUIDFLDO WHQVLRQ 6KHDULQJ HI¿FLHQF\ was also diminished at higher viscosities (27, 28) . Which results in the formation of larger particles. It was obvious that speed of the rotation of the propeller affects the yield and size distribution of microballoons (Table 1) . When the rotation speed of propeller was fast (1000 rpm), the average particle size decreased and their morphological characteristics were maintained. At low (250 rpm) URWDWLRQ VSHHG WKH VKHDU IRUFH ZDV QRW VXI¿FLHQW WR form stable emulsion droplets, as a consequence larger droplets were formed and they were aggregated eventually. Thus optimum rotation speed for formulations of this study was medium i.e.500 USP DV UHÀHFWHG IURP UHVXOWV RI SDUWLFOH VL]H DQG LQFRUSRUDWLRQ HI¿FLHQF\ IRUPXODWLRQ 3 6ROYHQW composition was found to be a vital factor in the formulation process governing the yield and particle size of microballoons ( Table 1) . As the amount of dichloromethane increased, the average particle size of microballoons was increased. Since alcohol preferentially diffused out of emulsion droplets, dichloromethane became a major constituent of the internal organic phase. The polymer, not being soluble at the interface between dichloromethane and aqueous phase, started to solidify around dichloromethane rich emulsion droplets and the volume of dichloromethane within the droplets became a size determining factor. The content of dichloromethane also affected the morphology of microballoons and best results were obtained at the ratio of alcohol to dichloromethane of 2:1 (formulation P12). The temperature of the dispersing medium was an important factor in the formation of microballoons, because it controls the rate of evaporation of the solvents (Table1). At lower temperature (8-10°C), the prepared microballoons had irregularly shaped surface morphology and the shell was translucent during the process, due to the slower rate of diffusion of ethanol. At higher temperatures, the shell of the microballoons was very thin and some of them were broken (formulation P16) which might be due to the faster diffusion of alcohol of the droplet into aqueous phase and immediate evaporation of dichloromethane after introduction into the medium. The optimum temperature for present study, to form PLFUREDOORRQV ZLWK JRRG ÀRDWLQJ SURSHUWLHV ZDV room temperature (formulation P15).
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By observation it was apparent that microballoons composed of HPMC at higher ratio (formulations P5, P6 and P7) were smaller in size as compared to microballoons with high EC content (Table1). Scanning electron micrograph (Fig 1) revealed that by using solvent diffusion and evaporation method spherical shaped microballoons with smooth outer surface and hollow core were formed. Incorporation HI¿FLHQF\ RI IRUPXODWHG PLFUREDOORRQV ZDV D IXQFWLRQ of process variables as well as the physicochemical properties of drug. It was observed that variation LQ SRO\PHU FRQFHQWUDWLRQ LQÀXHQFHG LQFRUSRUDWLRQ HI¿FLHQF\ 7DEOH ,QFUHDVH LQ YLVFRVLW\ DW KLJKHU polymer concentration restricted the movement of drug from polymer matrix into aqueous phase. Solubility of drug in organic solvents also played an important role in determination of the incorporation (29) . Results indicate that proportion of polymers in formulation was the key factor governing release of drug from microballoons. As the concentration of polymer increased, there was an increased in diffusional path length. This may decrease the overall drug release from the polymer matrix. Formulation comprised of EC in higher proportion exhibited much retarded drug release as compared to HPMC formulations (Figs 2A and 2B ). $QRWKHU SURFHVV YDULDEOH LQÀXHQFLQJ GUXJ UHOHDVH was agitation speed. At higher rotation speed smaller microballoons were formed resulting in higher drug UHOHDVH )LJ 1R VLJQL¿FDQW HIIHFW RI VROYHQW composition was observed on the in vitro release of cefpodoxime proxetil (Fig. 4) . It is apparent that the drug release, from microballoons prepared at high temperatures, was slightly higher by virtue of thin shell of the microballoons (Fig 5) . 
